Boston Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-9,700
| Closed | -$229K | – | 653 |
|
|
2018
Q3 | $229K | Hold |
9,700
| – | – | 0.01% | 608 |
|
|
2018
Q2 | $224K | Sell |
9,700
-14,444
| -60% | -$334K | 0.01% | 627 |
|
|
2018
Q1 | $595K | Sell |
24,144
-2,186
| -8% | -$53.9K | 0.02% | 466 |
|
|
2017
Q4 | $707K | Buy |
26,330
+11,130
| +73% | +$299K | 0.02% | 435 |
|
|
2017
Q3 | $366K | Sell |
15,200
-200
| -1% | -$4.82K | 0.01% | 546 |
|
|
2017
Q2 | $330K | Sell |
15,400
-1,600
| -9% | -$34.3K | 0.01% | 562 |
|
|
2017
Q1 | $291K | Sell |
17,000
-4,400
| -21% | -$75.3K | 0.01% | 567 |
|
|
2016
Q4 | $384K | Sell |
21,400
-24,050
| -53% | -$432K | 0.01% | 522 |
|
|
2016
Q3 | $945K | Sell |
45,450
-1,970
| -4% | -$41K | 0.02% | 361 |
|
|
2016
Q2 | $1.28M | Sell |
47,420
-4,220
| -8% | -$113K | 0.03% | 315 |
|
|
2016
Q1 | $1.4M | Sell |
51,640
-500
| -1% | -$13.5K | 0.03% | 286 |
|
|
2015
Q4 | $1.51M | Buy |
52,140
+17,490
| +50% | +$508K | 0.04% | 283 |
|
|
2015
Q3 | $940K | Buy |
34,650
+500
| +1% | +$13.6K | 0.04% | 385 |
|
|
2015
Q2 | $935K | Hold |
34,150
| – | – | 0.04% | 301 |
|
|
2015
Q1 | $912K | Sell |
34,150
-700
| -2% | -$18.7K | 0.04% | 303 |
|
|
2014
Q4 | $737K | Buy |
34,850
+300
| +0.9% | +$6.34K | 0.03% | 293 |
|
|
2014
Q3 | $823K | Hold |
34,550
| – | – | 0.04% | 294 |
|
|
2014
Q2 | $798K | Hold |
34,550
| – | – | 0.03% | 302 |
|
|
2014
Q1 | $789K | Buy |
34,550
+100
| +0.3% | +$2.28K | 0.04% | 292 |
|
|
2013
Q4 | $636K | Buy |
34,450
+12,750
| +59% | +$235K | 0.03% | 317 |
|
|
2013
Q3 | $367K | Buy |
21,700
+6,700
| +45% | +$113K | 0.02% | 362 |
|
|
2013
Q2 | $232K | Buy |
+15,000
| New | +$232K | 0.01% | 476 |
|